首页> 外文期刊>Journal of nanoscience and nanotechnology >Polymeric nanoparticles as drug controlled release systems: A new formulation strategy for drugs with small or large molecular weight
【24h】

Polymeric nanoparticles as drug controlled release systems: A new formulation strategy for drugs with small or large molecular weight

机译:高分子纳米颗粒作为药物控释系统:一种针对小分子量或大分子量药物的新制剂策略

获取原文
获取原文并翻译 | 示例
           

摘要

We report a study evaluating the encapsulation and release modalities from poly(D,L lactic acid) (PLA) or poly(D,L-lactide-co-glicolide) (PLGA) micro- and nano-particles of the antiischemic drug N-6-cyclopentyladenosine (CPA) and bovine serum albumin (BSA), chosen as protein model. The results obtained by classical preparation methods (nanoprecipitation, single or double emulsion/solvent evaporation) of the particles were compared with those obtained by their formulation with a novel method, employing a thermosensible gel of Pluronic F-127, whose aqueous solutions can be liquid when refrigerated, but gel upon warming. Our results indicate that CPA-loaded nanoparticles, obtained by classical methods, drastically reduce their drug content showing, moreover, any control of the drug release with respect to CPA-loaded microparticles. The novel preparation method allowed us to obtain, instead, CPA encapsulation values in nanoparticles similar to those obtained for microparticles, achieving also a weak control of the drug release. Any drastic reduction of BSA particle content was obtained by decreasing their size from micro- to nano-scales, independently on the employment of classical or novel preparation methods. Moreover, the size reduction induced only a weak increase of the BSA release rate. The patterns of protein released from micro- and nano-particles obtained by the same formulation method were similar. In particular, the micro- and nano-spheres prepared by double emulsion technique showed an incomplete BSA release, characterized by an elevated burst effect followed by a very slow phase. On the other hand, the release from micro- and nano-particles obtained by the novel method was complete and quite regular, being characterized by a little-burst release followed by a fast phase. These results have been related to the strong BSA distribution (observed by confocal laser scanning microscope) in the surface or in the core of microparticles obtained by the classical or novel methods, respectively.
机译:我们报告了一项研究,评估了抗缺血性药物N-的聚(D,L乳酸)(PLA)或聚(D,L-丙交酯-共-内酯)(PLGA)微粒和纳米颗粒的包封和释放方式选择6-环戊基腺苷(CPA)和牛血清白蛋白(BSA)作为蛋白质模型。将通过经典制备方法(纳米沉淀,单次或两次乳液/溶剂蒸发)获得的结果与采用新颖方法通过使用Pluronic F-127的热敏凝胶(其水溶液可以为液体)配制的结果进行比较。冷藏时,可在加热时凝结。我们的结果表明,通过经典方法获得的负载CPA的纳米颗粒大大降低了它们的药物含量,而且显示了相对于负载CPA的微粒的药物释放的任何控制。新颖的制备方法使我们能够获得类似于微粒获得的CPA纳米颗粒中的CPA包封值,从而实现了对药物释放的弱控制。通过将其尺寸从微米级减小到纳米级,可以大幅度降低BSA颗粒的含量,而与采用传统或新颖的制备方法无关。而且,尺寸减小仅引起BSA释放速率的微弱增加。通过相同的配制方法从微米和纳米颗粒释放的蛋白质的模式相似。特别地,通过双重乳液技术制备的微球和纳米球显示出不完全的BSA释放,其特征在于爆发效应升高,随后是非常缓慢的相。另一方面,通过该新方法获得的从微米和纳米颗粒的释放是完全且有规律的,其特征在于少量的爆发释放然后是快速的相。这些结果与分别通过经典或新颖方法获得的微粒的表面或核心中的强BSA分布(通过共聚焦激光扫描显微镜观察到)有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号